Adiponectin was also studied because it is inversely linked with insulin resistance, lipid accumulation, inflammation and NAFLD and increasing plasma adiponectin is being tested as a new therapy for NAFLD (69). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.